Published in Am J Transplant on November 01, 2003
BK virus nephritis after renal transplantation. Clin J Am Soc Nephrol (2008) 1.13
Management of polyomavirus-associated nephropathy in renal transplant recipients. Nat Rev Nephrol (2012) 1.10
BK virus infection, replication, and diseases in pediatric kidney transplantation. Pediatr Nephrol (2007) 1.05
The Banff 2009 Working Proposal for polyomavirus nephropathy: a critical evaluation of its utility as a determinant of clinical outcome. Am J Transplant (2012) 0.91
Adenovirus interstitial nephritis and rejection in an allograft. J Am Soc Nephrol (2011) 0.85
Polyomavirus allograft nephropathy and concurrent acute rejection: a diagnostic and therapeutic challenge. Am J Transplant (2004) 0.84
Antirejection treatment in kidney transplant patients with BK viruria. Transplantation (2008) 0.79
Clinical and pathological features of kidney transplant patients with concurrent polyomavirus nephropathy and rejection-associated endarteritis. World J Transplant (2015) 0.77
Immunophenotyping in BK virus allograft nephropathy distinct from acute rejection. Clin Dev Immunol (2013) 0.77
Tacrolimus Blood Level Fluctuation Predisposes to Coexisting BK Virus Nephropathy and Acute Allograft Rejection. Sci Rep (2017) 0.75
Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med (2010) 6.26
Tolerogenic immunosuppression for organ transplantation. Lancet (2003) 4.09
Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation (2005) 3.57
Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management. Transplantation (2002) 3.41
Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria. J Pediatr (2003) 1.71
Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. J Am Soc Nephrol (2004) 1.68
Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody. Transplantation (2008) 1.62
Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant (2003) 1.58
Loop-mediated isothermal amplification assay for rapid detection of common strains of Escherichia coli. J Clin Microbiol (2008) 1.55
Glomerular changes in BK virus nephropathy. Hum Pathol (2004) 1.54
Meta-analysis of medical regimen adherence outcomes in pediatric solid organ transplantation. Transplantation (2009) 1.54
Pediatric living donor kidney transplantation under alemtuzumab pretreatment and tacrolimus monotherapy: 4-year experience. Transplantation (2008) 1.52
Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg (2003) 1.52
Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation (2003) 1.47
Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol (2004) 1.46
Successful retransplantation after renal allograft loss to polyoma virus interstitial nephritis. Transplantation (2002) 1.43
Transplantation of en bloc pediatric kidneys when the proximal vascular cuff is too short. Transplantation (2007) 1.42
Proposed live donor nephrectomy complication classification scheme. Transplantation (2006) 1.41
Promotion of altruistic donation. Transplantation (2009) 1.33
Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system. Transplantation (2005) 1.32
Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg (2013) 1.30
Immunosuppression: practice and trends. Am J Transplant (2004) 1.28
The pathobiology of polyomavirus infection in man. Adv Exp Med Biol (2006) 1.27
Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy. Transplantation (2002) 1.23
Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody. Clin Infect Dis (2006) 1.23
Phylogenetic analysis of polyomavirus BK sequences. J Virol (2006) 1.19
Ether lipid ester derivatives of cidofovir inhibit polyomavirus BK replication in vitro. Antimicrob Agents Chemother (2006) 1.18
Update of PAX2 mutations in renal coloboma syndrome and establishment of a locus-specific database. Hum Mutat (2012) 1.15
Antibody-mediated rejection in kidney transplantation: a review. J Transplant (2012) 1.12
Quantitation of DNA of polyomaviruses BK and JC in human kidneys. J Infect Dis (2005) 1.12
Immunoglobulin G, A, and M responses to BK virus in renal transplantation. Clin Vaccine Immunol (2006) 1.12
Development of a loop-mediated isothermal amplification assay for rapid detection of BK virus. J Clin Microbiol (2007) 1.11
The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Liver Transpl (2002) 1.11
Distribution patterns of BK polyomavirus (BKV) subtypes and subgroups in American, European and Asian populations suggest co-migration of BKV and the human race. J Gen Virol (2009) 1.11
Single versus en bloc kidney transplantation from pediatric donors less than or equal to 15 kg. Transplantation (2008) 1.08
Pathogenesis and management of polyomavirus infection in transplant recipients. Clin Infect Dis (2002) 1.07
Comorbid conditions in kidney transplantation: association with graft and patient survival. J Am Soc Nephrol (2005) 1.06
Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches. Transpl Immunol (2005) 1.05
Early urethral (Foley) catheter removal positively affects length of stay after renal transplantation. Transplantation (2007) 1.03
Polyomavirus BK neutralizing activity in human immunoglobulin preparations. Transplantation (2010) 1.02
Long-term effects of alemtuzumab on regulatory and memory T-cell subsets in kidney transplantation. Transplantation (2012) 1.01
Inhibition of Simian Virus 40 replication by targeting the molecular chaperone function and ATPase activity of T antigen. Virus Res (2009) 1.00
A comparative study of BK and JC virus infections in organ transplant recipients. J Med Virol (2005) 0.99
DNA sequencing of viral capsid protein VP-1 region in patients with BK virus interstitial nephritis. Transplantation (2002) 0.99
Initial experience using histidine-tryptophan-ketoglutarate solution in clinical pancreas transplantation. Clin Transplant (2004) 0.98
Systemic anticoagulation and bleeding in children with hemodialysis catheters. Pediatr Nephrol (2002) 0.98
Pregnancy after kidney and kidney-pancreas transplantation under tacrolimus: a single center's experience. Transplantation (2004) 0.97
Renal cell carcinoma from a transplanted allograft: two case reports and a review of the literature. Clin Genitourin Cancer (2008) 0.96
Viral regulatory region sequence variations in kidney tissue obtained from patients with BK virus nephropathy. Kidney Int (2003) 0.95
Correlation of histologic findings on preimplant biopsy with kidney graft survival. Transpl Int (2008) 0.95
Measurements of global cell-mediated immunity in renal transplant recipients with BK virus reactivation. Am J Clin Pathol (2008) 0.95
Detection of CD8+ T cells sensitized to BK virus large T antigen in healthy volunteers and kidney transplant recipients. Hum Immunol (2006) 0.95
Lessons of organ-induced tolerance learned from historical clinical experience. Transplantation (2004) 0.94
Anti-BK virus activity of ciprofloxacin and related antibiotics. Clin Infect Dis (2005) 0.93
Kidney transplantation in elderly people: the influence of recipient comorbidity and living kidney donors. J Am Geriatr Soc (2007) 0.92
Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders. Am J Hypertens (2004) 0.92
Allospecific CD154+ T-cytotoxic memory cells identify recipients experiencing acute cellular rejection after renal transplantation. Transplantation (2011) 0.91
Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience. Transplantation (2004) 0.91
Monitoring for polyomavirus BK And JC in urine: comparison of quantitative polymerase chain reaction with urine cytology. Transplantation (2005) 0.90
Neutrophilic tubulitis as a marker for urinary tract infection in renal allograft biopsies with C4d deposition. Transplantation (2009) 0.90
The polyomavirus BK large T-antigen-derived peptide elicits an HLA-DR promiscuous and polyfunctional CD4+ T-cell response. Clin Vaccine Immunol (2011) 0.90
Cholesterol embolization in renal allografts: a clinicopathologic study of 12 cases. Am J Surg Pathol (2007) 0.89
Four-color flow cytometric analysis of peripheral blood donor cell chimerism. Hum Immunol (2003) 0.89
Diagnosis and treatment of BK virus-associated transplant nephropathy. Adv Exp Med Biol (2006) 0.89
Management of peripheral vascular disease compromising renal allograft placement and function: review of the literature with an illustrative case. Clin Transplant (2010) 0.89
Emerging role of donor-specific anti-human leukocyte antigen antibody determination for clinical management after solid organ transplantation. Hum Immunol (2009) 0.89
Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: long-term experience from a single center. Transplantation (2005) 0.89
Autosomal dominant progressive nephropathy with deafness: linkage to a new locus on chromosome 11q24. J Am Soc Nephrol (2003) 0.88
Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients. PLoS Pathog (2012) 0.88
Transplantation of a horseshoe kidney. Transplantation (2007) 0.88
Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients. Liver Transpl (2003) 0.88
HLA-A01-, -A03-, and -A024-binding nanomeric epitopes in polyomavirus BK large T antigen. Hum Immunol (2009) 0.87
Thyroid hormone in the treatment of post-transplant acute tubular necrosis (ATN). Am J Transplant (2002) 0.86
Long-term results of pediatric renal transplantation into a dysfunctional lower urinary tract. Transplantation (2003) 0.86
Colonic perforation by a dormant peritoneal dialysis catheter post renal transplantation. Am Surg (2010) 0.85
An official American Thoracic Society/International Society for Heart and Lung Transplantation/Society of Critical Care Medicine/Association of Organ and Procurement Organizations/United Network of Organ Sharing Statement: ethical and policy considerations in organ donation after circulatory determination of death. Am J Respir Crit Care Med (2013) 0.85
Proteomic analysis of urine in kidney transplant patients with BK virus nephropathy. J Am Soc Nephrol (2006) 0.85
Antihuman leukocyte antigen–specific antibody strength determined by complement-dependent or solid-phase assays can predict positive donor-specific crossmatches. Arch Pathol Lab Med (2010) 0.85
Polyomavirus BK non-coding control region rearrangements in health and disease. J Med Virol (2007) 0.85
Clinical significance of the distribution of C4d deposits in different anatomic compartments of the allograft kidney. Mod Pathol (2008) 0.85
Perceived discrimination predicts longer time to be accepted for kidney transplant. Transplantation (2012) 0.84
Psychological distress and adherence to the medical regimen among adolescent renal transplant recipients. Am J Transplant (2003) 0.84